Flumazenil for the Treatment of Primary Hypersomnia

Clinical trial NCT01183312 · COMPLETED

Trial details

NCT number: NCT01183312
Sponsor: Lynn Marie Trotti
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hypersomnia Primary Hypersomnia Idiopathic Hypersomnia Narcolepsy Without Cataplexy

Start date: 2010-09-01
Primary completion: 2012-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.